The Prostate Cancer Risk Calculator is designed to help you assess the likelihood of cancer being diagnosed after undergoing testing. To have confidence in the individual calculators you need to know that the underlying data is based on robust evidence gathered from the medical results of thousands of European men.

Evidence based on world’s largest prostate cancer screening study

Aged 55-74, these were men from Rotterdam in The Netherlands, already taking part in the European Randomized Study of Screening for Prostate Cancer. The ERSPC is the world’s largest study to find out whether the early detection of cancer by means of prostate specific antigen (PSA) testing could save lives. The Prostate Cancer Risk Calculator applies to men aged 55-74. Younger men have a much lower chance of being diagnosed with prostate cancer and this age group was therefore not included in the ERSPC study on which the data has been based.

For further information: Prostate Cancer Risk Calculator verification data (more) and ERSPC published findings (more)

As part of the European Randomized Study of Screening for Prostate Cancer, PSA test results from more than 20,000 men in the Rotterdam area were assessed and monitored over a twelve-year period. From this group, 6,288 men aged 55-74 met the strict criteria for inclusion in the separate risk calculator project.

These men also had two extra diagnostic tests – a rectal examination and an ultrasound to check for abnormalities and measure the volume of their prostate gland. Out of this group, 29% required additional investigations. Once these had been completed, only 6% were found to have prostate cancer (see table below).

Table showing results of this cancer detection study (on which Risk Calculator is based)